Ausgabe 3/2002
Inhalt (10 Artikel)
Budget impact model for determining the costs of introducing inhaled salmeterol/fluticasone propionate combination for the management of persistent asthma in France
B. Detournay, C. Pribil, C. Jourdanne, M. Price
Costs of toxicity during chemotherapy with CHOP, COP/CVP, and fludarabine
M. Herold, K. Hieke
A pharmacoeconomic evaluation of zuclopenthixol compared with haloperidol and risperidone in the treatment of schizophrenia
K. Hansen, C. François, M. Toumi, C. Lançon
Modelling the costs and effects of leflunomide in rheumatoid arthritis
G. Kobelt, P. Lindgren, A. Young
Medical savings accounts: a core feature of Singapore's health care system
W. von Eiff, T. Massoro, Y. O. Voo, R. Ziegenbein
Methodological guidelines for conducting economic evaluation of healthcare interventions in Hungary: a Hungarian proposal for methodology standards
Ágota Szende, Z. Mogyorósy, N. Muszbek, J. Nagy, G. Pallos, C Dözsa
Restructuring of the healthcare system and the diffusion of telemedicine
M. Kerleau, N. Pelletier-Fleury
Pricing and reimbursement of pharmaceuticals in Norway
A. Hågå, J. M. Sverre